Loading...
SMID is not a good buy right now. Price action is weakening (bearish MACD expansion) and the stock is trading below/near key levels (pivot 36.423 vs price 35.24) with nearby support at 34.76 that could still break. With the latest quarter showing YoY declines across revenue, earnings, and margin, there isn’t a strong catalyst to justify an impatient entry today. I would hold off rather than buy at this moment.
Trend/momentum looks bearish-to-neutral. MACD histogram is -0.159 and negatively expanding (bearish momentum building). RSI(6) at 34.98 is near oversold but still categorized as neutral here—suggesting a possible bounce attempt, not a confirmed reversal. Moving averages are converging (no strong trend confirmation). Key levels: price 35.24 is below the pivot (36.423). Immediate support S1 is 34.76 (very close); if it fails, next support S2 is 33.732. Resistance levels to reclaim for a bullish turn: 36.423 pivot first, then R1 38.087.
Intellectia Proprietary Trading Signals
with RSI near oversold, which can sometimes fuel a short-term bounce. Pattern-based projection suggests modest upside potential over a month (+2.44%).
Bearish momentum is strengthening (MACD negative and expanding) while price sits below the pivot and is pressing close to support (34.76), raising breakdown risk. No meaningful supportive trading trends from hedge funds or insiders (both neutral). The only provided news item appears ETF/NAV-related and not a direct company-specific catalyst for SMID.
Latest reported quarter: 2025/Q3. Revenue fell to 21.451M (-9.04% YoY), net income 2.877M (-8.67% YoY), EPS 0.54 (-8.47% YoY), and gross margin 26.85% (-3.73% YoY). Overall, the quarter shows decelerating fundamentals rather than growth acceleration.
No analyst rating/price-target changes were provided in the data, so there’s no observable recent Street trend to support a pro-buy case. Wall Street pros/cons view cannot be reliably inferred here due to missing coverage details.
